Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Psychol Med ; 49(16): 2646-2656, 2019 12.
Article in English | MEDLINE | ID: mdl-31559935

ABSTRACT

To identify genetic risk loci for major depressive disorder (MDD), two broad study design approaches have been applied: (1) to maximize sample size by combining data from different phenotype assessment modalities (e.g. clinical interview, self-report questionnaires) and (2) to reduce phenotypic heterogeneity through selecting more homogenous MDD subtypes. The value of these strategies has been debated. In this review, we summarize the most recent findings of large genomic studies that applied these approaches, and we highlight the merits and pitfalls of both approaches with particular attention to methodological and psychometric issues. We also discuss the results of analyses that investigated the heterogeneity of MDD. We conclude that both study designs are essential for further research. So far, increasing sample size has led to the identification of a relatively high number of genomic loci linked to depression. However, part of the identified variants may be related to a phenotype common to internalizing disorders and related traits. As such, samples containing detailed clinical information are needed to dissect depression heterogeneity and enable the potential identification of variants specific to a more restricted MDD phenotype. A balanced portfolio reconciling both study design approaches is the optimal approach to progress further in unraveling the genetic architecture of depression.


Subject(s)
Depression/genetics , Depressive Disorder, Major/genetics , Genetic Predisposition to Disease , Genome-Wide Association Study , Genetic Loci , Humans , Multifactorial Inheritance , Phenotype , Polymorphism, Single Nucleotide , Risk Factors
3.
Eur J Clin Nutr ; 71(8): 987-994, 2017 08.
Article in English | MEDLINE | ID: mdl-28466848

ABSTRACT

BACKGROUND/OBJECTIVES: To investigate the association of dietary patterns derived by reduced rank regression (RRR) with depressive symptoms in a multi-ethnic population. SUBJECTS/METHODS: Cross-sectional data from the HELIUS study were used. In total, 4967 men and women (18-70 years) of Dutch, South-Asian Surinamese, African Surinamese, Turkish and Moroccan origin living in the Netherlands were included. Diet was measured using ethnic-specific food frequency questionnaires. Depressive symptoms were measured with the nine-item patient health questionnaire. RESULTS: By performing RRR in the whole population and per ethnic group, comparable dietary patterns were identified and therefore the dietary pattern for the whole population was used for subsequent analyses. We identified a dietary pattern that was strongly related to eicosapentaenoic acid+docosahexaenoic acid, folate, magnesium and zinc (response variables) and which was characterized by milk products, cheese, whole grains, vegetables, legumes, nuts, potatoes and red meat. After adjustment for confounders, a statistically significant inverse association was observed in the whole population (B: -0.03, 95% CI: -0.06, -0.00, P=0.046) and among Moroccan (B: -0.09, 95% CI: -0.13, -0.04, P=0.027) and South-Asian Surinamese participants (B: -0.05, 95% CI: -0.09, -0.01, P=<0.001), whereas no statistically significant association was found in the remaining ethnic groups. No statistically significant associations were found between the dietary pattern and significant depressed mood in any of the ethnic groups. CONCLUSIONS: No consistent evidence was found that consumption of a dietary pattern, high in nutrients that are hypothesized to protect against depression, was associated with lower depressive symptoms across different ethnic groups.


Subject(s)
Depression/etiology , Depression/prevention & control , Diet, Healthy , Diet/adverse effects , Health Status Disparities , Patient Compliance , Urban Health , Adult , Asian People , Cohort Studies , Confounding Factors, Epidemiologic , Cost of Illness , Cross-Sectional Studies , Depression/epidemiology , Depression/ethnology , Diet/ethnology , Diet, Healthy/ethnology , Female , Humans , Male , Morocco/ethnology , Netherlands/epidemiology , Patient Compliance/ethnology , Prevalence , Registries , Risk , Suriname/ethnology , Turkey/ethnology , Urban Health/ethnology
4.
Behav Genet ; 47(3): 360-368, 2017 05.
Article in English | MEDLINE | ID: mdl-28185111

ABSTRACT

Population divergence impacts the degree of population stratification in Genome Wide Association Studies. We aim to: (i) investigate type-I error rate as a function of population divergence (FST) in multi-ethnic (admixed) populations; (ii) evaluate the statistical power and effect size estimates; and (iii) investigate the impact of population stratification on the results of gene-based analyses. Quantitative phenotypes were simulated. Type-I error rate was investigated for Single Nucleotide Polymorphisms (SNPs) with varying levels of FST between the ancestral European and African populations. Type-II error rate was investigated for a SNP characterized by a high value of FST. In all tests, genomic MDS components were included to correct for population stratification. Type-I and type-II error rate was adequately controlled in a population that included two distinct ethnic populations but not in admixed samples. Statistical power was reduced in the admixed samples. Gene-based tests showed no residual inflation in type-I error rate.


Subject(s)
Genetics, Population/methods , Genome-Wide Association Study/methods , Polymorphism, Single Nucleotide , Humans
5.
Eur Neuropsychopharmacol ; 25(6): 808-16, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25907250

ABSTRACT

Although antipsychotics are widely prescribed, their effect of on improving poor illness insight in schizophrenia has seldom been investigated and therefore remains uncertain. This paper examines the effects of low dose haloperidol, amisulpride, olanzapine, quetiapine, and ziprasidone on insight in first-episode schizophrenia, schizoaffective disorder, or schizophreniform disorder. The effects of five antipsychotic drugs in first episode psychosis on insight were compared in a large scale open randomized controlled trial conducted in 14 European countries: the European First-Episode Schizophrenia Trial (EUFEST). Patients with at least minimal impairments in insight were included in the present study (n=455). Insight was assessed with item G12 of the Positive and Negative Syndrome Scale (PANSS), administered at baseline and at 1, 3, 6, 9, and 12 months after randomization. The use of antipsychotics was associated with clear improvements in insight over and above improvements in other symptoms. This effect was most pronounced in the first three months of treatment, with quetiapine being significantly less effective than other drugs. Effects of spontaneous improvement cannot be ruled out due to the lack of a placebo control group, although such a large spontaneous improvement of insight would seem unlikely.


Subject(s)
Antipsychotic Agents/therapeutic use , Schizophrenia/drug therapy , Adolescent , Adult , Analysis of Variance , Dose-Response Relationship, Drug , Europe/epidemiology , Female , Humans , Longitudinal Studies , Male , Psychiatric Status Rating Scales , Retrospective Studies , Treatment Outcome , Young Adult
6.
J Affect Disord ; 166: 115-23, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25012419

ABSTRACT

BACKGROUND: An important biological factor suggested in the pathophysiology of (recurrent) Major Depressive Disorder (MDD) concerns a polymorphism in a gene encoding for the MTHFR-enzyme of the one-carbon (1-C)-metabolism. Integratively investigating key 1-C-components (folate, homocysteine, vitamin B6 and B12), including the possible effects of antidepressant medication and depressive state, could provide more insight in the possible association between the MTHFR-polymorphism and recurrent MDD. METHODS: We compared the MTHFR C677T-polymorphism together with the key 1-C-components in clinically ascertained patients with recurrent MDD (n=137) to age- and gender-matched healthy controls (n=73). RESULTS: First, patients had lower folate (t=2.25; p=.025) as compared to controls; a difference that resolved after correction for demographics (t=1.22; p=.223). Second, patients that were depressed during sampling had lower vitamin B6 (t=-2.070; p=.038) and higher homocysteine (t=2.404; p=.016) compared to those in remission. Finally, current use of antidepressants had no influence on the 1-C-components. CONCLUSIONS: Despite investigation of a specific recurrently depressed patient population, we found no clear associations with the 1-C-cycle, except for higher homocysteine and lower vitamin B6 during the depressed state. This suggests that 1-C-cycle alterations in MDD are state-associated, possibly resulting from high levels of acute (psychological) stress, and may provide a treatment target to reduce cardiovascular risk in this population.


Subject(s)
Antidepressive Agents/therapeutic use , Carbon/metabolism , Depressive Disorder, Major/drug therapy , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Polymorphism, Genetic , Adult , Case-Control Studies , Depressive Disorder, Major/genetics , Female , Folic Acid/blood , Homocysteine/blood , Humans , Male , Middle Aged , Recurrence , Vitamin B 12/blood , Vitamin B 6/blood
7.
Psychol Med ; 44(12): 2673-83, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24957628

ABSTRACT

BACKGROUND: Cross-sectional and longitudinal studies have shown a positive association between attention deficit hyperactivity disorder (ADHD) and problematic alcohol use in adults. To what extent this association is explained by genetic and environmental factors is largely unknown. METHOD: Data on ADHD and alcohol consumption were collected by self-report in 6024 adult Dutch twins. ADHD symptoms were assessed by three subscales of the Conners' Adult ADHD Rating Scales - Self-Report: Screening Version (CAARS-S:SV): inattentiveness, hyperactivity and the ADHD index (ADHD-I). Problem drinking was defined as at least two self-reported alcohol-related problems on the CAGE questionnaire. Structural equation modelling was applied to the bivariate twin data to estimate genetic and environmental influences. RESULTS: Heritability of ADHD symptoms ranged between 32% and 40% and heritability of problem drinking was 50%. The positive correlation between ADHD symptoms and problem drinking was confirmed in this general population sample, with phenotypic correlations between 0.20 and 0.28 and genetic correlations between 0.39 and 0.50. Phenotypic correlations are primarily (61-100%) explained by genetic influences with non-shared environmental influences explaining the remaining covariance. No significant quantitative or qualitative gender differences in covariance structure were found. CONCLUSIONS: This study convincingly shows that ADHD symptoms and problem drinking are moderately but significantly correlated in adults and that genetic correlations are primarily underlying this association. This suggests that early interventions are required to prevent adolescents with ADHD from developing problematic levels of alcohol use. Furthermore, clinicians who treat alcohol-dependent patients should be aware that the patient may have a co-morbid condition of ADHD; integrated interventions are required.


Subject(s)
Alcohol-Related Disorders/genetics , Attention Deficit Disorder with Hyperactivity/genetics , Diseases in Twins/genetics , Adult , Alcohol-Related Disorders/epidemiology , Alcohol-Related Disorders/etiology , Attention Deficit Disorder with Hyperactivity/epidemiology , Attention Deficit Disorder with Hyperactivity/etiology , Comorbidity , Diseases in Twins/epidemiology , Diseases in Twins/etiology , Female , Gene-Environment Interaction , Humans , Male , Middle Aged , Netherlands/epidemiology , Self Report
8.
Mol Psychiatry ; 19(2): 228-34, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23319000

ABSTRACT

Studying genetic determinants of intermediate phenotypes is a powerful tool to increase our understanding of genotype-phenotype correlations. Metabolic traits pertinent to the central nervous system (CNS) constitute a potentially informative target for genetic studies of intermediate phenotypes as their genetic underpinnings may elucidate etiological mechanisms. We therefore conducted a genome-wide association study (GWAS) of monoamine metabolite (MM) levels in cerebrospinal fluid (CSF) of 414 human subjects from the general population. In a linear model correcting for covariates, we identified one locus associated with MMs at a genome-wide significant level (standardized ß=0.32, P=4.92 × 10(-8)), located 20 kb from SSTR1, a gene involved with brain signal transduction and glutamate receptor signaling. By subsequent whole-genome expression quantitative trait locus (eQTL) analysis, we provide evidence that this variant controls expression of PDE9A (ß=0.21; P unadjusted=5.6 × 10(-7); P corrected=0.014), a gene previously implicated in monoaminergic transmission, major depressive disorder and antidepressant response. A post hoc analysis of loci significantly associated with psychiatric disorders suggested that genetic variation at CSMD1, a schizophrenia susceptibility locus, plays a role in the ratio between dopamine and serotonin metabolites in CSF. The presented DNA and mRNA analyses yielded genome-wide and suggestive associations in biologically plausible genes, two of which encode proteins involved with glutamate receptor functionality. These findings will hopefully contribute to an exploration of the functional impact of the highlighted genes on monoaminergic transmission and neuropsychiatric phenotypes.


Subject(s)
Biogenic Monoamines/cerebrospinal fluid , Gene Expression , Genome-Wide Association Study , Homovanillic Acid/cerebrospinal fluid , Hydroxyindoleacetic Acid/cerebrospinal fluid , Methoxyhydroxyphenylglycol/cerebrospinal fluid , 3',5'-Cyclic-AMP Phosphodiesterases/genetics , Adult , Chromosomes, Human, Pair 11 , Female , Genetic Loci , Genetic Variation , Genotyping Techniques , Humans , Linear Models , Male , Membrane Proteins/genetics , Mental Disorders/genetics , Polymorphism, Single Nucleotide , Tumor Suppressor Proteins
9.
Psychol Med ; 43(11): 2339-47, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23448697

ABSTRACT

BACKGROUND: Several cognitive biases are related to psychotic symptoms, including auditory verbal hallucinations (AVH). It remains unclear whether these biases differ in voice-hearers with and without a 'need-for-care'. METHOD: A total of 72 healthy controls, 72 healthy voice-hearers and 72 clinical voice-hearers were compared on the Cognitive Biases Questionnaire for psychosis (CBQp), which assesses 'intentionalizing', 'jumping to conclusions', 'catastrophizing', 'dichotomous thinking' and 'emotional reasoning' in vignettes characterized by two themes, 'threatening events' and 'anomalous perceptions'. RESULTS: Healthy voice-hearers scored intermediately on total CBQp between the control and clinical groups, differing significantly from both. However, on four out of five biases the scores of the healthy voice-hearers were comparable with those of the healthy controls. The only exception was 'emotional reasoning', on which their scores were comparable with the clinical group. Healthy voice-hearers demonstrated fewer biases than the psychotic patients on the 'threatening events', but not the 'anomalous perceptions', vignettes. CBQp scores were related to both cognitive and emotional, but not physical, characteristics of voices. CONCLUSIONS: Most cognitive biases prevalent in clinical voice-hearers, particularly with threatening events themes, are absent in healthy voice-hearers, apart from emotional reasoning which may be specifically related to the vulnerability to develop AVH. The association between biases and both beliefs about voices and distress/emotional valence is consistent with the close links between emotions and psychotic phenomena identified by cognitive models of psychosis. The absence of reasoning biases might prevent the formation of threatening appraisals about anomalous experiences, thereby reducing the likelihood of distress and 'need for care'.


Subject(s)
Cognition Disorders/psychology , Cognition , Hallucinations/psychology , Psychotic Disorders/psychology , Adult , Case-Control Studies , Female , Humans , Male , Middle Aged , Surveys and Questionnaires
10.
Schizophr Res ; 147(1): 132-139, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23537477

ABSTRACT

UNLABELLED: Studies and meta-analyses investigating the influence of substance use disorder (SUD) (substance abuse or dependence) on psychopathology and neurocognitive function in schizophrenia patients have revealed controversial results. Most studies did only have small samples and did not focus exclusively on first-episode schizophrenia patients. METHOD: In a post-hoc analysis of the European First Episode Schizophrenia Trial (EUFEST) psychopathology and cognitive performances of patients with (FE-SUD, N=119, consisting of N=88 patients with persisting SUD at baseline and N=31 patients with previous SUD) and without SUD (FE-non-SUD, N=204) were compared at baseline and 6 months follow-up. Neurocognitive assessment included the Rey Auditory Verbal Learning Test (RAVLT); Trail Making Tests A and B (TMT), Purdue Pegboard and Digit-Symbol Coding. RESULTS: In total 31.1% of patients reported SUD, and 22.2% of patients used cannabis. There were no significant differences between patients with and without SUD concerning PANSS scores, extrapyramidal motor symptoms or neurocognitive measures except better performance in psychomotor speed (TMT-A, p=0.033, Cohen's d=0.26) in patients with SUD at 6 months follow-up. Interestingly, SUD patients with ongoing substance use at follow-up showed elevated positive symptoms (PANSS positive score, p=0.008, Cohen's d=0.84) compared to those who abstained. PANSS scores at baseline were increased in patients with an onset of SUD before the age of 16 years. In addition we found a correlation between longer duration of cannabis use and higher cognitive performance as well as reduced symptom improvement and more extrapyramidal motor symptoms in patients with higher frequency of cannabis consumption. CONCLUSIONS: FE-SUD and FE-non-SUD show similar psychopathology and neuropsychological performances at baseline and during the first 6 months of antipsychotic treatment.


Subject(s)
Antisocial Personality Disorder/etiology , Cognition Disorders/etiology , Schizophrenia/complications , Schizophrenia/epidemiology , Schizophrenic Psychology , Substance-Related Disorders , Adult , Analysis of Variance , Antipsychotic Agents/therapeutic use , Chlorpromazine/therapeutic use , Europe/epidemiology , Female , Humans , Male , Neuropsychological Tests , Schizophrenia/drug therapy , Substance-Related Disorders/complications , Substance-Related Disorders/epidemiology , Substance-Related Disorders/psychology , Verbal Learning , Young Adult
11.
Psychol Med ; 43(12): 2563-70, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23410598

ABSTRACT

BACKGROUND: Schizophrenia is associated with lower pre-morbid intelligence (IQ) in addition to (pre-morbid) cognitive decline. Both schizophrenia and IQ are highly heritable traits. Therefore, we hypothesized that genetic variants associated with schizophrenia, including copy number variants (CNVs) and a polygenic schizophrenia (risk) score (PSS), may influence intelligence. METHOD: IQ was estimated with the Wechsler Adult Intelligence Scale (WAIS). CNVs were determined from single nucleotide polymorphism (SNP) data using the QuantiSNP and PennCNV algorithms. For the PSS, odds ratios for genome-wide SNP data were calculated in a sample collected by the Psychiatric Genome-Wide Association Study (GWAS) Consortium (8690 schizophrenia patients and 11 831 controls). These were used to calculate individual PSSs in our independent sample of 350 schizophrenia patients and 322 healthy controls. RESULTS: Although significantly more genes were disrupted by deletions in schizophrenia patients compared to controls (p = 0.009), there was no effect of CNV measures on IQ. The PSS was associated with disease status (R 2 = 0.055, p = 2.1 × 10-7) and with IQ in the entire sample (R 2 = 0.018, p = 0.0008) but the effect on IQ disappeared after correction for disease status. CONCLUSIONS: Our data suggest that rare and common schizophrenia-associated variants do not explain the variation in IQ in healthy subjects or in schizophrenia patients. Thus, reductions in IQ in schizophrenia patients may be secondary to other processes related to schizophrenia risk.


Subject(s)
Endophenotypes , Intelligence/genetics , Schizophrenia/genetics , Adult , DNA Copy Number Variations/genetics , Female , Genetic Predisposition to Disease , Genome-Wide Association Study , Humans , Male , Multifactorial Inheritance/genetics , Polymorphism, Single Nucleotide , Wechsler Scales
12.
Schizophr Res ; 143(2-3): 354-7, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23245702

ABSTRACT

Patients with schizophrenia are more likely to develop diabetes mellitus (DM) compared to the general population. In relatives, however, an increased rate of DM has not consistently been reported. In this study, we compared DM rates in 1740 unaffected first- and second-/third-degree relatives of patients with a non-affective psychotic disorder to 1271 control subjects, by administering the Family Interview for Genetic Studies (FIGS). The prevalence of DM (6.1%) was increased in the relatives of patients as compared to the relatives of the healthy subjects (3.6%, OR=1.6, p=0.007). Our findings support the hypothesis of a familial, possibly genetic, link between DM and non-affective psychotic disorders.


Subject(s)
Diabetes Mellitus/epidemiology , Diabetes Mellitus/genetics , Psychotic Disorders/genetics , Adult , Aged , Aged, 80 and over , Comorbidity , Female , Genetic Predisposition to Disease , Humans , Male , Middle Aged , Pedigree , Prevalence , Psychotic Disorders/epidemiology
13.
Psychol Med ; 42(12): 2475-84, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22716897

ABSTRACT

BACKGROUND: Hallucinations have consistently been associated with traumatic experiences during childhood. This association appears strongest between physical and sexual abuse and auditory verbal hallucinations (AVH). It remains unclear whether traumatic experiences mainly colour the content of AVH or whether childhood trauma triggers the vulnerability to experience hallucinations in general. In order to investigate the association between hallucinations, childhood trauma and the emotional content of hallucinations, experienced trauma and phenomenology of AVH were investigated in non-psychotic individuals and in patients with a psychotic disorder who hear voices. METHOD: A total of 127 non-psychotic individuals with frequent AVH, 124 healthy controls and 100 psychotic patients with AVH were assessed for childhood trauma. Prevalence of childhood trauma was compared between groups and the relation between characteristics of voices, especially emotional valence of content, and childhood trauma was investigated. RESULTS: Both non-psychotic individuals with AVH and patients with a psychotic disorder and AVH experienced more sexual and emotional abuse compared with the healthy controls. No difference in the prevalence of traumatic experiences could be observed between the two groups experiencing AVH. In addition, no type of childhood trauma could distinguish between positive or negative emotional valence of the voices and associated distress. No correlations were found between sexual abuse and emotional abuse and other AVH characteristics. CONCLUSIONS: These results suggest that sexual and emotional trauma during childhood render a person more vulnerable to experience AVH in general, which can be either positive voices without associated distress or negative voices as part of a psychotic disorder.


Subject(s)
Hallucinations/diagnosis , Hallucinations/psychology , Life Change Events , Personality Development , Psychotic Disorders/diagnosis , Psychotic Disorders/psychology , Schizophrenia/diagnosis , Schizophrenic Psychology , Speech Perception , Adolescent , Adult , Age of Onset , Child , Cross-Sectional Studies , Female , Hallucinations/epidemiology , Humans , Male , Middle Aged , Netherlands , Psychotic Disorders/epidemiology , Risk Factors , Statistics as Topic , Young Adult
14.
Schizophr Res ; 138(2-3): 171-6, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22534419

ABSTRACT

BACKGROUND: There is considerable variation in progressive brain volume changes in schizophrenia. Whether this is related to the clinical heterogeneity that characterizes the illness remains to be determined. This study examines the relationship between change in brain volume over time and individual variation in psychopathology, as measured by five continuous symptom dimensions (i.e. negative, positive, disorganization, mania and depression). METHODS: Global brain volume measurements from 105 schizophrenia patients and 100 healthy comparison subjects, obtained at inclusion and 5-year follow-up, were used in this study. Symptom dimension scores were calculated by factor analysis of clinical symptoms. Using linear regression analyses and independent-samples t-tests, the relationship between symptom dimensions and progressive brain volume changes, corrected for age, gender and intracranial volume, was examined. Antipsychotic medication, outcome and IQ were investigated as potential confounders. RESULTS: In patients, the disorganization dimension was associated with change in total brain (ß=-0.295, p=0.003) and cerebellar (ß=-0.349, p<0.001) volume. Furthermore, higher levels of disorganization were associated with lower IQ, irrespective of psychiatric status (i.e. patient or control). In healthy comparison subjects, disorganization score was not associated with progressive brain volume changes. CONCLUSION: Heterogeneity in progressive brain volume changes in schizophrenia is particularly associated with variation in disorganization. Schizophrenia patients with high levels of disorganization exhibit more progressive decrease of global brain volumes and have lower total IQ. We propose that these patients form a phenotypically and biologically homogenous subgroup that may be useful for etiological (e.g., genetic) studies.


Subject(s)
Affective Symptoms/pathology , Brain/pathology , Depression/pathology , Schizophrenia, Disorganized/pathology , Schizophrenia/pathology , Schizophrenic Psychology , Adolescent , Adult , Case-Control Studies , Disease Progression , Female , Humans , Longitudinal Studies , Magnetic Resonance Imaging , Male , Middle Aged , Organ Size
15.
Mol Psychiatry ; 17(5): 474-85, 2012 May.
Article in English | MEDLINE | ID: mdl-21670730

ABSTRACT

In this article, we review some of the data that contribute to our understanding of the genetic architecture of psychiatric disorders. These include results from evolutionary modelling (hence no data), the observed recurrence risk to relatives and data from molecular markers. We briefly discuss the common-disease common-variant hypothesis, the success (or otherwise) of genome-wide association studies, the evidence for polygenic variance and the likely success of exome and whole-genome sequencing studies. We conclude that the perceived dichotomy between 'common' and 'rare' variants is not only false, but unhelpful in making progress towards increasing our understanding of the genetic basis of psychiatric disorders. Strong evidence has been accumulated that is consistent with the contribution of many genes to risk of disease, across a wide range of allele frequencies and with a substantial proportion of genetic variation in the population in linkage disequilibrium with single-nucleotide polymorphisms (SNPs) on commercial genotyping arrays. At the same time, most causal variants that segregate in the population are likely to be rare and in total these variants also explain a significant proportion of genetic variation. It is the combination of allele frequency, effect size and functional characteristics that will determine the success of new experimental paradigms such as whole exome/genome sequencing to detect such loci. Empirical results suggest that roughly half the genetic variance is tagged by SNPs on commercial genome-wide chips, but that individual causal variants have a small effect size, on average. We conclude that larger experimental sample sizes are essential to further our understanding of the biology underlying psychiatric disorders.


Subject(s)
Genetic Predisposition to Disease/genetics , Mental Disorders/genetics , Humans , Multifactorial Inheritance , Polymorphism, Genetic/genetics
16.
Psychol Med ; 42(7): 1461-73, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22099529

ABSTRACT

BACKGROUND: This study aimed to identify the course of unmet needs by patients with a first episode of schizophrenia and to determine associated variables. METHOD: We investigated baseline assessments in the European First Episode Schizophrenia Trial (EUFEST) and also follow-up interviews at 6 and 12 months. Latent class growth analysis was used to identify patient groups based on individual differences in the development of unmet needs. Multinomial logistic regression determined the predictors of group membership. RESULTS: Four classes were identified. Three differed in their baseline levels of unmet needs whereas the fourth had a marked decrease in such needs. Main predictors of class membership were prognosis and depression at baseline, and the quality of life and psychosocial intervention at follow-up. Depression at follow-up did not vary among classes. CONCLUSIONS: We identified subtypes of patients with different courses of unmet needs. Prognosis of clinical improvement was a better predictor for the decline in unmet needs than was psychopathology. Needs concerning social relationships were particularly persistent in patients who remained high in their unmet needs and who lacked additional psychosocial treatment.


Subject(s)
Health Services Needs and Demand/statistics & numerical data , Models, Statistical , Quality of Life/psychology , Schizophrenia/therapy , Schizophrenic Psychology , Acute Disease , Adolescent , Adult , Europe , Female , Humans , Interpersonal Relations , Longitudinal Studies , Male , Patient Dropouts/statistics & numerical data , Psychiatric Status Rating Scales/statistics & numerical data , Reproducibility of Results , Schizophrenia/epidemiology , Time Factors , Young Adult
17.
Behav Genet ; 40(4): 564-71, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20232132

ABSTRACT

There is increasing interest in methods to disentangle the relationship between genotype and (endo)phenotypes in human complex traits. We present a population-based method of increasing the power and cost-efficiency of studies by selecting random individuals with a particular genotype and then assessing the accompanying quantitative phenotypes. Using statistical derivations, power- and cost graphs we show that such a "forward genetics" approach can lead to a marked reduction in sample size and costs. This approach is particularly apt for implementing in epidemiological studies for which DNA is already available but the phenotyping costs are high.


Subject(s)
Genetics, Population/economics , Genetics, Population/methods , Genetics, Population/statistics & numerical data , Genome-Wide Association Study/methods , Genome-Wide Association Study/statistics & numerical data , Models, Genetic , Computational Biology/methods , Computational Biology/statistics & numerical data , Genotype , Humans , Phenotype , Quantitative Trait, Heritable
18.
Neuroscience ; 164(1): 16-29, 2009 Nov 24.
Article in English | MEDLINE | ID: mdl-19409224

ABSTRACT

Attention deficit hyperactivity disorder (ADHD) is to a large extent influenced by genetic factors, but environmental influences are considered important as well. To distinguish between functional brain changes underlying primarily genetically and environmentally mediated ADHD, we used functional magnetic resonance imaging (fMRI) to compare response interference in monozygotic twins highly concordant or discordant for attention problems (AP). AP scores were assessed longitudinally with the Child Behavior Check List attention problem scale (CBCL-AP). Response interference was measured during two executive function paradigms; a color-word Stroop and a flanker task. The neuroimaging results indicated that, across the entire sample, children with high CBCL-AP scores, relative to children with low CBCL-AP scores, showed decreased activation to response interference in dorsolateral prefrontal, parietal and temporal brain regions. Increased activation was noted in the premotor cortex and regions associated with visual selective attention processing, possibly reflecting compensatory mechanisms to maintain task performance. Specific comparisons of high and low scoring concordant twin pairs suggest that AP of genetic origin was characterized by decreased activation of the left dorsolateral prefrontal cortex during the Stroop task and right parietal lobe during the flanker task. In contrast, comparison of twins from discordant monozygotic pairs, suggests that AP of environmental origin was characterized by decreased activation in left and right temporal lobe areas, but only during Stroop interference. The finding of distinct brain activation changes to response interference in inattention/hyperactivity of "genetic" versus "environmental" origin, indicates that genetic and environmental risk factors for attention/hyperactivity problems affect the brain in different ways.


Subject(s)
Attention Deficit Disorder with Hyperactivity/physiopathology , Attention/physiology , Brain/physiopathology , Diseases in Twins/physiopathology , Adolescent , Attention Deficit Disorder with Hyperactivity/etiology , Attention Deficit Disorder with Hyperactivity/genetics , Brain Mapping , Diseases in Twins/etiology , Diseases in Twins/genetics , Environment , Female , Genetic Predisposition to Disease , Humans , Longitudinal Studies , Magnetic Resonance Imaging , Male , Neuropsychological Tests , Psychiatric Status Rating Scales , Stroop Test , Twins
19.
Neuroimage ; 35(3): 1004-20, 2007 Apr 15.
Article in English | MEDLINE | ID: mdl-17346990

ABSTRACT

Several structural brain abnormalities have been reported in patients with Attention Deficit Hyperactivity Disorder (ADHD). However, the etiology of these brain changes is still unclear. To investigate genetic and environmental influences on ADHD related neurobiological changes, we performed Voxel-Based Morphometry on MRI scans from monozygotic (MZ) twins selected from a large longitudinal population database to be highly concordant or highly discordant for ratings on the Child Behavior Checklist Attention Problem scale (CBCL-AP). Children scoring low on the CBCL-AP are at low risk for ADHD, whereas children scoring high on this scale are at high-risk for ADHD. Brain differences between concordant high-risk twin pairs and concordant low-risk twin pairs likely reflect the genetic risk for ADHD; brain differences between the low-risk and high-risk twins from discordant MZ twin pairs reflect the environmental risk for ADHD. A major difference between comparisons of high and low-risk twins from concordant pairs and high/low twins from discordant pairs was found for the prefrontal lobes. The concordant high-risk pairs showed volume loss in orbitofrontal subdivisions. High-risk members from the discordant twin pairs exhibited volume reduction in the right inferior dorsolateral prefontal cortex. In addition, the posterior corpus callosum was compromised in concordant high-risk pairs, only. Our findings indicate that inattention and hyperactivity symptoms are associated with anatomical abnormalities of a distributed action-attentional network. Different brain areas of this network appear to be affected in inattention/hyperactivity caused by genetic (i.e., high concordant MZ pairs) vs. environmental (i.e., high-low discordant MZ pairs) risk factors. These results provide clues that further our understanding of brain alterations in ADHD.


Subject(s)
Aging/pathology , Attention Deficit Disorder with Hyperactivity/genetics , Attention Deficit Disorder with Hyperactivity/pathology , Brain/pathology , Diseases in Twins/genetics , Diseases in Twins/pathology , Magnetic Resonance Imaging/methods , Attention Deficit Disorder with Hyperactivity/epidemiology , Child , Child, Preschool , Diseases in Twins/epidemiology , Evidence-Based Medicine , Female , Genetic Predisposition to Disease/epidemiology , Genetic Predisposition to Disease/genetics , Heterozygote , Humans , Incidence , Infant , Infant, Newborn , Magnetic Resonance Imaging/statistics & numerical data , Male , Netherlands/epidemiology , Risk Assessment/methods , Risk Factors , Twin Studies as Topic/statistics & numerical data
20.
Behav Genet ; 36(6): 833-44, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16773450

ABSTRACT

The goal of the present study is to examine genetic and environmental influences on maternal and teacher ratings of Attention Problems (AP) in 7-year-old children. Teachers completed the Teacher Report Form (N=2259 pairs), and mothers the Child Behavior Checklist (N=2057 pairs). Higher correlations were found in twins rated by the same teacher than in twins rated by different teachers. This can be explained by rater bias or by a greater environmental sharing in twins, who are in the same classroom. We further found that 41% of the variation in maternal and teacher ratings is explained by a common factor. The heritability of this common factor is 78%. The heritabilities of the rater specific factors of mothers and teachers are 76% and 39%, respectively. Because Attention Problems that are persistent over situations may indicate more serious behavior problems than context dependent Attention Problems, we believe that gene finding strategies should focus on this common phenotype.


Subject(s)
Attention Deficit Disorder with Hyperactivity/genetics , Mother-Child Relations , Teaching , Adult , Attention/physiology , Attention Deficit Disorder with Hyperactivity/epidemiology , Child , Female , Humans , Longitudinal Studies , Models, Genetic , Models, Psychological , Netherlands , Twins, Dizygotic , Twins, Monozygotic
SELECTION OF CITATIONS
SEARCH DETAIL
...